![David Hanley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hanley
Directeur Technique/Scientifique/R&D chez
NUVATION BIO INC.
Fortune : 151 920 $ au 31/07/2026
Profil
David C.
Hanley is Chief Technical Operations Officer at Nuvation Bio, Inc. since 2021.
Formerly, Senior Director-Global Pharmaceutical Development at The Medicines Co. from 2011 to 2014, VP-Pharmaceutical Sciences & Technical Operations at Radius Health, Inc. from 2014 to 2018, and Senior VP & Head-Global Pharmaceutical Development at BioXcel Therapeutics, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Utah and an undergraduate degree from Virginia Commonwealth University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/02/2026 | 24 000 ( 0,01 % ) | 151 920 $ | 31/07/2026 |
Postes actifs de David Hanley
| Sociétés | Poste | Début |
|---|---|---|
| NUVATION BIO INC. | Directeur Technique/Scientifique/R&D | 01/06/2021 |
Anciens postes connus de David Hanley
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2021 |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/08/2018 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01/08/2014 |
Formation de David Hanley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Commonwealth University
 Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
